Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Accounts Payables (2023 - 2025)

Historic Accounts Payables for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $717000.0.

  • Profound Medical's Accounts Payables fell 1015.04% to $717000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $717000.0, marking a year-over-year decrease of 1015.04%. This contributed to the annual value of $1.3 million for FY2024, which is 5225.43% up from last year.
  • According to the latest figures from Q3 2025, Profound Medical's Accounts Payables is $717000.0, which was down 1015.04% from $949000.0 recorded in Q2 2025.
  • In the past 5 years, Profound Medical's Accounts Payables registered a high of $1.3 million during Q4 2024, and its lowest value of $542000.0 during Q1 2024.
  • Over the past 3 years, Profound Medical's median Accounts Payables value was $831500.0 (recorded in 2023), while the average stood at $855000.0.
  • Examining YoY changes over the last 5 years, Profound Medical's Accounts Payables showed a top increase of 9335.79% in 2025 and a maximum decrease of 1015.04% in 2025.
  • Over the past 3 years, Profound Medical's Accounts Payables (Quarter) stood at $865000.0 in 2023, then soared by 52.25% to $1.3 million in 2024, then crashed by 45.56% to $717000.0 in 2025.
  • Its last three reported values are $717000.0 in Q3 2025, $949000.0 for Q2 2025, and $1.0 million during Q1 2025.